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Objective: To determine whether the presence or severity of pain is predictive of suboptimal weight loss
outcomes in behavioral weight management programs.
Methods: This is a secondary data analysis comparing weight loss among participants with overweight/
obesity who participated in a 12-month randomized controlled trial. Of the 481 participants randomized,
394 (81.9%) had available pain data and were categorized by Pain Type (back pain, arthritis pain, both,
or neither) and Pain Severity (no pain, moderate pain, or severe pain). Dietary and physical activity out-
comes were also explored.
Results: High rates of moderate and severe (80.2%), and back and arthritis (72.6%), pain were observed.
Linear mixed models showed significant differences in % weight loss among Pain Severity, but not Pain
Type, groups. Patients with severe pain lost significantly less weight (20.1 kg, 95% CI521.5, 21.2)
compared to those with either moderate or no pain (21.9 kg, 95% CI522.5, 21.3; 22.1 kg, 95%
CI523.3, 21.0, respectively). Patients with arthritis pain lost a significant amount of weight despite only
minor improvements in walking distance.
Conclusions: Pain severity, but not pain type, is predictive of suboptimal weight loss outcomes.
Obesity (2015) 23, 1778–1784. doi:10.1002/oby.21160
Introduction
Pain and obesity are two of the most pressing health problems in
the United States (US) due to their high prevalence and associated
medical morbidity (1). It is relatively unknown whether pain
patients obtain suboptimal weight outcomes with behavioral weight
loss treatments. While there is some evidence to suggest that pain
patients will do better when offered more intensive treatment com-
pared to less intensive treatment (2-4), this is also true for patients
in general (5).
Pain and obesity are of particular concern to the Veterans Health
Administration (VHA) because of the high prevalence of both
among veterans. The prevalence for overweight/obesity in VHA is
76.9% (6), making it 10% higher than the US general population
average (7). Veterans also appear to be disproportionately affected
with higher rates of specific pain-related conditions, such as low
back pain (8). While there is considerable variability in rates
reported due to a lack of consistency in pain assessment (9), national
surveys report that between 19% (10) and 43% (11) of the general
population is affected by chronic pain.
Given that higher body mass index (BMI) is a risk factor for having
a chronic pain condition (12,13), it is not surprising that the obesity
epidemic has been implicated as one of the major contributors to the
rise in chronic pain (9), predicting both its onset and progression
(14). The relationship is also bi-directional with chronic pain con-
tributing, in part, to the rise in obesity (15). The complex and recip-
rocating relationship between the two, and the high prevalence of
each individually and in co-occurrence, have implications for the
treatment of both.
Studies clearly show that weight loss produces decreased pain and
disability in chronic pain patients (16-19). However, there are clini-
cal concerns that pain interferes with one’s ability to lose weight,
and some circumstantial evidence supports the notion that pain may
be a barrier toward compliance with weight loss treatment as
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individuals report eating in response to pain and avoiding physical
activity because of pain (20,21). Three randomized controlled trials
of overweight patients with knee pain have shown that more inten-
sive weight loss programs produce better outcomes (2-4). For exam-
ple, programs that combine diet with exercise, or diet with pain cop-
ing skills, have better weight and pain outcomes than exercise alone
(2), diet without pain coping skills (3), or diabetes education (4).
Given that these studies were all conducted with pain patients, it is
not known how outcomes might differ between pain and non-pain
patients when both groups are administered the same treatment.
Given the high prevalence of pain and overweight/obesity among the US
population (7,10), further investigation is warranted to understand the
impact of pain on weight loss. The objective of the current study is to con-
duct the first longitudinal investigation of pain type and pain severity as
potential predictors of weight loss in an outpatient behavioral weight
management program. We aim to investigate whether weight loss out-
comes differ among groups with different types and severity of pain.
Methods
Study design
This is a secondary data analysis comparing weight loss and clinical out-
comes based on pain type and pain severity among treatment-seeking
participants with overweight/obesity. Data was obtained from the Aspir-
ing to Lifelong Health Program in Veterans Affairs (ASPIRE-VA) trial
(22,23), a randomized controlled trial of 481 participants designed to
evaluate the effectiveness of a small changes weight loss intervention
(ASPIRE) compared to the standard VHA weight management program
(MOVE!VR ). Participants were randomized to one of three treatment
arms, stratified by sites: (1) the ASPIRE weight loss program delivered
individually over the phone (ASPIRE-Phone), (2) the ASPIRE weight
loss program delivered via in-person group sessions (ASPIRE-Group);
or (3) MOVE!
VR
delivered primarily in group format as usual care. Insti-
tutional Review Board approval was obtained at two Midwestern VA
medical centers, Louis Stokes Cleveland VA Medical Center (Cleve-
land) and VA Ann Arbor Healthcare System (Ann Arbor), that served as
recruitment and treatment sites.
Participants and procedures
Eligible participants were primary care provider- or self-referred for
weight management services and eligible for the MOVE! program (22).
Candidates were invited to participate if they had a BMI>5 30 kg/m2, or
had a BMI between 25–30 kg/m2 and at least one obesity-related health
condition (e.g., type 2 diabetes). Other inclusion criteria were an ability to
communicate in English, competency to provide informed consent, and
reliable access to a telephone. Exclusion criteria were: current enrollment
in another treatment or study involving weight loss or physical activity;
inability to complete a 6-minute walking test (6MWT) (24); or preg-
nancy. Of the 481 participants randomized to ASPIRE-VA, 394 partici-
pants had available pain data, and were included in the present study (i.e.
data was missing for 87 participants from the original study). Enrollment
began January 2010 and 12-month follow-up assessments were com-
pleted by November 2012.
Pain categorization and measures
Pain categories were obtained with two baseline assessment instru-
ments. Pain Type was assessed by administering the MOVE!23 Sur-
vey, a 23-item self-report instrument designed to evaluate domains
related to obesity and weight management (25). Data on its psycho-
metric properties have been reported (26), including it discriminate
validity with regard to pain (27). Participants are asked: “Please
indicate (with a check mark to the left) any of the following that
apply to you.” Response items include a list of health conditions,
two of which are pain-related: back pain or spinal disc disease
(BACK), and arthritis or joint pain (ARTHRITIS). Participants who
checked neither pain-related condition were categorized as NEI-
THER, and those who checked both pain-related conditions were
categorized as BOTH, following a previously validated method (27).
Pain Severity was assessed with the EuroQoL-3D (28), a standar-
dized instrument for measurement of health outcomes. The Pain/Dis-
comfort item from the EuroQoL was used to categorize participants
based upon the following response set: I have no pain or discomfort
(NO PAIN), I have moderate pain or discomfort (MODERATE
PAIN), and I have extreme pain or discomfort (SEVERE PAIN).
At baseline, demographic and clinical data were obtained, includ-
ing potentially relevant psychiatric and medical covariates chosen
based upon prior research with this patient population (27). In-
ternational Statistical Classification of Diseases, 9th Revision, Clin-
ical Modification (ICD-9-CM) codes from electronic medical
records were obtained for post-traumatic stress disorder (PTSD;
309.81), depression (293.83, 296.2, 296.3, 296.90, 296.99, 300.4,
301.12, 309.0, 309.1, and 311), and substance use disorder (SUD;
291, 292, 303, 304, 305.0, 305.2–305.9). ICD-9 codes were also
used to obtain a composite measure of medical comorbidity using
the Charlson Index, a validated measure of disease burden based
upon age and presence of 19 conditions with high likelihood of
mortality (29).
The primary outcome for the present study was % weight loss at 12
months, measured as a continuous variable. For descriptive pur-
poses, results have been presented for change in absolute weight
(kg), BMI (weight (kg)/height (m2)) and waist circumference (cm),
as well as % weight loss, from baseline to 12 months. The second-
ary outcome was the percent of participants who achieved clinically
significant weight loss (5% weight loss) at 12 months, measured
by a categorical variable (05 no, 15 yes). Exploratory analyses
were performed for the 6MWT (24), an objective measure of func-
tional exercise capacity (30), and the self-reported Food Frequency
Questionnaire (31) a measure of dietary fiber, fat, and fruit/vegeta-
ble intake. These measures were assessed at three time points, and
participants received remuneration for completing an assessment at
baseline ($20), 3 months ($20), and 12 months ($50).
Statistical analyses
Analyses were performed in Stata, version 13.1 (College Station,
TX). Descriptive statistics were calculated for all variables using
Pearson Chi-square test for categorical variables and analysis of var-
iance for continuous variables.
Linear mixed models were used to model the primary and explora-
tory analyses at 3 and 12 months post-randomization using all avail-
able data. Two separate models were built for each of the a priori
set of pain categories (Pain Type and Pain Severity) with either
NEITHER or NO PAIN as the reference group. Treatment arms
were pooled for the purposes of this study to investigate pain as a
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predictor of weight loss outcome. The following independent varia-
bles were controlled for in the models: treatment arm, site, pain cat-
egory, time, and time by pain category interaction. Additional demo-
graphic and/or psychiatric variables were controlled for given
baseline differences observed among pain categories. This included
age, depression, and PTSD for Pain Type, and age, race, depression,
PTSD and SUD for Pain Severity.
Chi-square analysis was used for the secondary outcome. Two anal-
yses were performed to examine whether those in the reference
groups (NEITHER or NO PAIN) were more likely to achieve clini-
cally significant weight loss (5% weight loss) compared to the
other pain category groups. These analyses were performed for the
347 randomized participants who completed 12-month assessments
(88.1% of the sample).
Results
Characteristics of the overall sample
Participants were predominately middle aged (M5 55.6, SD5 9.8),
moderately obese (M BMI5 36.4, SD5 6.2) men (n5 335, 85%).
The sample was ethnically diverse with 42% (n5 165) non-white
(the majority of which were African American). Rates of depression,
PTSD and substance use disorders were 32.0%, 16.5% and 16.5%,
respectively, and the mean Charlson Index was 1.2 comorbid condi-
tions (SD5 1.5, range 0 to 9).
Overall, the total sample (N5 394) experienced a mean % weight
loss of 1.71% (CI522.20, 21.22, P5 0.001), and 21.9% (n5 76)
of the 347 who completed 12-month assessment achieved clinically
significant weight loss (5% weight loss). Improvements were
observed for the other weight outcomes as well such that BMI
(M520.60, CI520.78, 20.43, P< 0.001) and waist circumfer-
ence (M522.51 cm, CI523.16, 21.86, P< 0.001) significantly
decreased. Walking distance (as measured by the 6MWT) signifi-
cantly increased (M5 17.4 meters, CI5 11.56, 23.26, P< 0.001).
Among the dietary outcomes, percent of fat intake significantly
decreased (M521.26, CI521.78, 20.74, P< 0.001), fruit and
vegetable servings significantly increased (M5 0.22, CI5 0.03,
0.42, P5 0.026), and no change in fiber content was observed
(M520.51, CI521.40, 0.37, P5 0.256).
The frequencies for Pain Type were 27.4% (n5 108) for NEITHER,
12.9% (n5 51) for BACK, 26.9% (n5 106) for ARTHRITIS and
32.7% (n5 129) for BOTH. The frequencies for Pain Severity were
19.8% (n5 78) for NO PAIN, 67.8% (n5 267) for MODERATE,
and 12.4% (n5 49) for SEVERE. Overall, 72.6% (n5 286) of par-
ticipants reported back, arthritis or both types of pain, and 80.2%
(n5 316) reported moderate or severe pain.
Demographic and clinical characteristics by pain
categories
Tables 1 and 2 show comparisons of baseline demographic and clin-
ical characteristics by Pain Type and Pain Severity. Across the Pain
Type groups, there were significant differences for age, BMI, waist
circumference, and presence of ICD-9 depression and PTSD. The
ARTHRITIS group was significantly older than the BACK and NEI-
THER groups, and the two groups with arthritis (ARTHRITIS and
TABLE 1 Baseline comparisons for Pain Type groups
Neither Back Arthritis Both Total
N 108 51 106 129 394
Male, n (%) 92 (85.2) 41 (80.4) 95 (89.6) 107 (82.9) 335 (85.0)
Age, mean (SD) 53.5 (11.0) 54.1 (8.5) 58.5**^^ (8.5) 55.61 (9.9) 55.6 (9.8)
Race
African American, n (%) 48 (44.4) 23 (45.1) 39 (36.8) 47 (36.4) 157 (39.8)
Other, n (%) 4 (3.7) 1 (2.0) 0 (0.0) 3 (2.3) 8 (2.0)
Caucasian, n (%) 56 (51.9) 27 (52.9) 67 (63.2) 79 (61.2) 229 (58.1)
Baseline weight measures
Weight (kg), mean (SD) 109 (24.3) 111 (20.2) 115 (23.0) 114 (22.4) 113 (22.9)
BMI (kg/m2), mean (SD) 35.2 (6.5) 35.1 (5.1) 37.4**^ (6.2) 37.1*^ (6.1) 36.4 (6.2)
Waist (cm), mean (SD) 116 (16.2) 118 (14.2) 122** (15.0) 122** (15.5) 120 (15.6)
Comorbidity
Depression, n (%) 24 (22.2) 20* (39.2) 26 (24.5) 56**11 (43.4) 126 (32.0)
Post-traumatic stress 13 (12.0) 11 (21.6) 9^ (8.5) 32**11 (24.8) 65 (16.5)
disorder, n (%)
Substance use disorder, n (%) 12 (11.1) 11 (21.6) 15 (14.2) 27 (20.9) 65 (16.5)
Charlson Index, mean (SD) 1.0 (1.3) 1.2 (1.7) 1.3 (1.5) 1.2 (1.6) 1.2 (1.5)
*P-value<0.05 compared to NEITHER.
**P-value< 0.01 compared to NEITHER.
P^-value< 0.05 compared to BACK.
^^P-value< 0.01 compare to BACK.
1P-value<0.05 compared to ARTHRITIS.
11P-value< 0.01 compared to ARTHRITIS.
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BOTH) had significantly higher BMI and larger waist circumference
than those groups as well. The BOTH group had significantly higher
percentages of participants with ICD-9-CM diagnoses of depression
and PTSD compared to the NEITHER and ARTHRITIS groups.
Among the Pain Severity groups, depression, PTSD and SUD were
observed in significantly greater percentages for the MODERATE
and SEVERE groups compared to the NO PAIN group.
With regard to treatment completion rates, there were no significant dif-
ferences among Pain Type (P5 0.40) or Pain Severity (P5 0.37) groups.
Comparisons by pain type
Table 3 shows results of the linear mixed models for the primary out-
come, descriptive weight outcomes, and the exploratory outcomes. For
the primary outcome of % weight loss, there was no significant differ-
ence (adjusted model, P5 0.46) among Pain Type groups. There were
also no significant differences for the descriptive weight outcomes of
weight (kg), BMI and waist circumference (all P’s> 0.05). For the
secondary outcome of clinically significant weight loss, there was no
significant difference in adjusted or unadjusted rates [unadjusted v2
(3)5 1.07, P5 0.78]. Figure 1 depicts the weight changes (kg) from
baseline to 12 months for the four Pain Type groups.
For the exploratory outcomes, walking distance increased for partici-
pants in all groups, but the magnitude of the change was signifi-
cantly less for the ARTHRITIS and BOTH groups compared to the
NEITHER and BACK groups (all P’s< 0.01). No significant differ-
ences in dietary outcomes were observed among the four groups (all
P’s> 0.05). Given the significant difference in age across the Pain
Type groups, all analyses were rerun with age as an additional cova-
riate with comparable results.
Comparisons by pain severity
Table 4 shows results of the linear mixed models for the primary
outcome, descriptive weight outcomes, and the exploratory out-
comes. For the primary outcome, the NO PAIN and MODERATE
PAIN groups had significantly greater reductions in % weight loss
compared to the SEVERE PAIN group (P’s< 0.05).The SEVERE
PAIN group did not lose or gain weight. There were also significant
differences for the descriptive weight outcomes of Weight, BMI and
waist circumference such that the NO PAIN and MODERATE
PAIN groups had significantly greater reductions in these measures
compared to the SEVERE PAIN group. For the secondary outcome
of clinically significant weight loss, there was no significant differ-
ence in adjusted or unadjusted rates [unadjusted v2 (2)5 0.66,
p5 0.720]. Figure 2 depicts the weight changes (kg) from baseline
to 12 months for the three Pain Severity groups.
In the exploratory analysis, the MODERATE PAIN group exhibited
significantly less change in 6MWT distance compared to the NO
PAIN group (P< 0.01). No significant differences in dietary out-
comes were observed among the three groups (all P’s> 0.05).
Discussion
This is the first study to prospectively investigate the presence and
impact of pain type and severity on weight loss. High rates of pain
were observed in this sample of participants with overweight/obesity
who were seeking weight management treatment in the VHA. Mod-
erate or severe pain was reported in over 80% of sample partici-
pants, and nearly three-quarters reported back and/or arthritis pain.
Consistent with our findings, other studies have reported very high
rates of pain among participants with overweight/obesity [10,12],
TABLE 2 Baseline comparisons for Pain Severity groups
No Pain Moderate Severe Total
N 78 267 49 394
Male, n (%) 64 (82.1) 227 (85.0) 44 (89.8) 335 (85.0)
Age, mean (SD) 53.4 (12.8) 56.3* (8.9) 55.2 (8.9) 55.6 (9.8)
Race
African American, n (%) 26 (33.3) 105 (39.3) 26* (53.1) 157 (39.8)
Other, n (%) 4 (5.1) 4 (1.5) 0 (0.0) 8 (2.0)
Caucasian, n (%) 48 (61.5) 158 (59.2) 23 (46.9) 229 (58.1)
Baseline weight measures
Weight (kg), mean (SD) 107 (21.4) 114* (22.8) 113 (24.5) 113 (22.9)
BMI (kg/m2), mean (SD) 35.6 (6.0) 36.7 (6.1) 36.0 (6.6) 36.4 (6.2)
Waist (cm), mean (SD) 117 (15.7) 121 (15.3) 120 (17.1) 120 (15.6)
Comorbidity
Depression, n (%) 11 (14.1) 92** (34.5) 23** (46.9) 126 (32.0)
Post-traumatic stress 2 (2.6) 50** (18.7) 13** (26.5) 65 (16.5)
disorder, n (%)
Substance use disorder, n (%) 4 (5.1) 52** (19.5) 9* (18.4) 65 (16.5)
Charlson Index, mean (SD) 0.9 (1.2) 1.2 (1.6) 1.3 (1.6) 1.2 (1.5)
* P-value< 0.05 compared to NO PAIN.
** P-value< 0.01 compared to NO PAIN.
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including a national VHA sample that found similar rates of back
and arthritis pain (27).
Most notably, our study showed that for the 12% of the sample who
reported severe pain, % weight loss was significantly less than for
those with moderate or no pain. Specifically, individuals reporting
severe pain, on average, did not gain or lose weight during the 12-
month treatment. However, pain severity did not predict the percent
who achieved clinically significant weight loss, and pain type did
not predict either % weight loss or the percent who achieved clini-
cally significant weight loss.
One question raised by these findings is whether weight manage-
ment interventions need to be bolstered for patients with severe
Figure 1 Adjusted weight change at 3 and 12 months based on linear mixed effects models controlling
for treatment arm, baseline BMI, pain type, visit, and visit by pain type interaction.
TABLE 3 Adjusted comparisons of outcomes for Pain Type groupsa
Neither Back Arthritis Both
Primary outcome
% Weight loss 22.0 21.5 22.1 21.3
(22.9 to 21.0) (22.9 to 20.1) (23.0 to 21.2) (22.1 to 20.4)
Descriptive weight outcomes
Weight (kg) 22.1 21.6 22.3 21.5
(23.1 to 21.0) (23.1 to 20.0) (23.3 to 21.3) (22.4 to 20.5)
BMI (kg/m2) 20.6 20.5 20.8 20.5
(21.0 to 20.3) (21.0 to 0.0) (21.1 to 20.4) (20.8 to 20.2)
Waist (cm) 23.2 22.6 22.3 22.1
(24.4 to 21.9) (24.5 to 20.7) (23.5 to 21.0) (23.3 to 20.9)
Exploratory outcomes
6-min walk (m) 33.3 35.2 6.4**^^ 3.6**^^
(22.2 to 44.3) (18.4 to 52.1) (24.6 to 17.5) (27.1 to 14.2)
Fiber (gm) 0.3 20.9 21.3 20.9
(21.4 to 2.1) (23.3 to 1.6) (23.0 to 0.4) (22.5 to 0.6)
% Fat (gm) 21.5 21.2 21.4 21.3
(22.5 to 20.5) (22.6 to 0.3) (22.4 to 20.4) (22.2 to 20.4)
Fruit/veg (svgs) 0.5 20.1 0.1 0.2
(0.1 to 0.9) (20.7 to 0.4) (20.3 to 0.4) (20.1 to 0.6)
Values given as mean (95% CI).
aPredicted 12-month changes for each outcome variable based on linear mixed models. Independent variables included time (as 12-months indicator), treatment arm indi-
cators, site, baseline value of the outcome variable, age, depression, post-traumatic stress disorder, Pain Type (with NEITHER as reference group), time, and time by Pain
Type interaction.
**P-value <0.01 compared to NEITHER.
^^P-value <0.01 compared to BACK.
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pain. Of note is that participants in our study had gained 3.16 kg
(95% CI5 1.99, 4.34; N5 394), or 6.97 lbs (95% CI5 4.38m 9.57),
in the 12 months prior to study initiation, a similar finding to previ-
ous research reporting steep weight gain trajectories prior to VHA
weight management treatment (32,33). Thus, weight management
treatment likely slowed the rate of weight gain for those with severe
pain even though they did not experience the same level of benefit
as individuals with moderate or no pain. Weight stabilization, rather
than weight loss, may be an important initial goal for those with
severe pain. Despite the disparate mean weight loss outcomes for
participants with and without severe pain, a similar proportion of
participants achieved clinically significant weight loss.
Another important finding was that participants with arthritis, either
alone or in combination with back pain, had less improvement in
walking distance during a timed test, compared to participants with
back pain only or neither type of pain. Even though inferior
improvements in walking were observed among participants with
arthritis, they exhibited comparable outcomes with regard to weight.
While patients may state they avoid physical activity because of
pain (20), our findings suggest that longitudinal improvement in
walking distance may not be necessary for successful weight out-
come, however the impact on weight loss maintenance is unknown.
Our results are consistent with findings from the only other study to
examine the relationship between pain and weight loss (34). In that
retrospective chart review of men and women with obesity who had
enrolled in a four-week residential weight loss program, pain type
and frequency of pain types, did not predict weight change after
controlling for the effects of depression (34). Our findings show that
pain type is not predictive of weight loss in even longer (12
months), outpatient treatment. In addition, our study extends find-
ings to include pain severity. In contrast to reports that patients eat
in response to pain (20) we did not find that dietary outcomes dif-
fered by presence or absence of pain type or severity in this longitu-
dinal trial.
This study has a number of limitations. Pain type, while determined
by the MOVE!23 survey using previously validated methodology
(27), was limited to back and arthritis pain. Although these two are
the most common types of pain (9), they do not account for other
types of chronic pain (e.g., fibromyalgia) that were likely present
even in the NEITHER condition. Thus, the current study probably
observed weaker associations between outcomes, and back and
arthritis pain, than what would have been found with a comparison
Figure 2 Adjusted weight change at 3 and 12 months based on linear mixed effects models controlling
for treatment arm, baseline BMI, pain severity, visit, and visit by pain severity interaction.
TABLE 4 Adjusted comparisons of outcomes for Pain Severity
groupsa
No Pain Moderate Severe
Primary outcome
% Weight loss 22.1 21.9 20.1*^
(23.3 to 21.0) (22.5 to 21.3) (21.5 to 1.2)
Descriptive weight outcomes
Weight (kg) 22.2 22.1 20.3^
(23.5 to 20.9) (22.7 to 21.4) (21.8 to 1.2)
BMI (kg/m2) 20.7 20.7 20.1*^
(21.1 to 20.3) (20.9 to 20.5) (20.5 to 0.4)
Waist (cm) 23.3 22.6 20.4*^
(24.8 to 21.8) (23.4 to 21.9) (22.2 to 1.4)
Exploratory outcomes
6-min walk (m) 33.0 12.0** 16.0
(19.4 to 46.7) (4.9 to 19.2) (21.4 to 33.5)
Fiber (gm) 21.2 20.8 0.9
(23.2 to 0.8) (21.9 to 0.2) (21.6 to 3.3)
% Fat (gm) 21.8 21.3 21.1
(23.0 to 20.7) (21.9 to 20.6) (22.5 to 0.3)
Fruit/veg (svgs) 0.1 0.2 0.5
Values given as mean (95% CI).
aPredicted 12-month changes for each outcome variable based on linear mixed
models. Independent variables included time (as 12-months indicator), treatment
arm indicators, site, baseline value of the outcome variable, age, race, depression,
post-traumatic stress disorder, substance use disorder, Pain Severity (with NO
PAIN as reference group), time, and time by Pain Severity interaction.
*P-value<0.05 compared to NO PAIN.
**P-value< 0.01 compared NO PAIN.
P^-value< 0.05 compared to MODERATE.
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group truly without pain. Another limiting factor was the small
overall weight loss obtained in the ASPIRE-VA trial (21.71% or
21.87 kg) that may have made it less likely to find significant effect
sizes. Finally, our findings may not generalize to other populations
as study subjects were older male participants with overweight/obe-
sity who participated in a weight loss clinical trial through the VHA
at two Midwestern states.
This is the first study to prospectively demonstrate that severe pain
predicts poor 12-month outpatient weight loss outcomes. However,
findings from this study also suggest that moderate pain is not a bar-
rier to weight loss and that weight management interventions should
be encouraged in patients regardless of their type of pain. Implica-
tions from the present findings are that individuals with severe pain
may need modified, or more targeted interventions to achieve signif-
icant weight loss. Alternatively, first focusing on stopping weight
gain among those with severe pain may be another treatment
approach for interventionists. Results from the present study also
suggest that clinicians should encourage weight management for
participants with arthritis pain as these patients have been shown to
lose comparable amounts of weight even with minor improvements
in walking distance.
In sum, pain severity, but not pain type, is predictive of suboptimal
weight loss outcomes. Our findings have important implications for
the clinical care of patients with the combined problems of pain and
overweight/obesity. Providers should not be reluctant to refer these
patients to weight loss treatment. Even patients with the most severe
pain are likely to achieve weight stabilization, and those with arthri-
tis pain may expect good weight loss outcomes. Primary care pro-
viders and medical home teams may benefit from understanding the
role of pain in weight management treatment.O
VC 2015 The Obesity Society
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